Abstract
In light of the increased risk of vaccine-associated paralytic poliomyelitis (VAPP) in India the Technical Consultative Group will have to revise its estimate of the global burden of VAPP and explore the possibility of replacing oral polio vaccine (OPV) with inactivated polio vaccine in order to avoid VAPP. In scientific and ethical terms eradication must result in the total absence of poliomyelitis due to any polioviruses wild or vaccine-related. (excerpt)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
